1180586

NABRIVA THERAPEUTICS US INC — FEI 3019658754

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 2, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Fort Washington, PA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)